Royal College of Physicians appoints obesity special adviser
The Royal College of Physicians has appointed consultant in bariatric medicine, diabetes and endocrinology, Dr Kath McCullough as its new...
top of page
Browse by category
Search
Novo Nordisk to initiate study assessing CagriSema vs Tirzepatide
Novo Nordisk is planning a study that will see CagriSema, a new investigational medicine developed by Novo that combines Cagrilintide and...
Fractyl expands ERASE Task Force to study underlying GLP-1-based pancreatic gene therapy for T2DM
Fractyl Health has expanded an academic-industry scientific partnership charged with advancing research on the role of the gut and...
Carmot begins Phase 2 trial of dual GLP-1/GIP RA CT-868 for the treatment of type 1 diabetes
Carmot Therapeutics has commenced a Phase 2 clinical trial of its once-daily dual GLP-1/GIP receptor agonist, CT-868, in adult...
People with obesity burn less energy during day
A study by researcher at Oregon Health & Science University has found people who have a healthy weight use more energy during the day,...
Journal Watch 15/11/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Updates on banded procedure studies and randomised controlled trials
At the recent International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) World Congress in Naples, Italy,...
SELECT: Semaglutide reduces CV events in non-diabetic patients with overweight or obesity
Semaglutide 2.4mg (Wegovy) reduces cardiovascular events in patients with overweight or obesity and pre-existing cardiovascular disease...
Lilly's Mounjaro (tirzepatide) receives UK marketing authorisation for weight management
Eli Lilly and Company has granted marketing authorisation (MA) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for...
Low risk of bowel resection is low in patients presenting with small bowel obstruction post-RYGB
The overall risk of bowel resection is low in patients having small bowel obstruction after Roux-en-Y gastric bypass (RYGB) and the risk...
Browse by tag
bottom of page